logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

INSILICO (03696) issued 14.2035 million shares by exercising all excess rights issue.

date
20:30 21/01/2026
avatar
GMT Eight
English Silicon Intelligence (03696) announced that on January 21, 2026, it issued 14.2035 million shares in accordance with the full exercise of the rights issue.
INSILICO (03696) announced that on January 21, 2026, 14.2035 million shares were issued through the full exercise of the excess rights issue.
Related Articles
HK Stock
MARKETINGFORCE (02556) spent 1.6908 million Hong Kong dollars to repurchase 35,700 shares on January 21st.
US Stock Market Move | Berkshire Hathaway reduces its stake in Kraft Heinz Company (KHC.US) by 27.5%, causing the stock to drop over 7% in pre-market trading.
HK Stock
BOAN BIOTECH (06955): Shandong LUYE PHARMA plans to further transfer 38.5 million H shares of the company to Luye Geneora Holding.
MARKETINGFORCE (02556) spent 1.6908 million Hong Kong dollars to repurchase 35,700 shares on January 21st.
HK Stock
US Stock Market Move | Berkshire Hathaway reduces its stake in Kraft Heinz Company (KHC.US) by 27.5%, causing the stock to drop over 7% in pre-market trading.
BOAN BIOTECH (06955): Shandong LUYE PHARMA plans to further transfer 38.5 million H shares of the company to Luye Geneora Holding.
HK Stock
RECOMMEND
Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
icon
21/01/2026
China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
icon
21/01/2026
Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
icon
21/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.